
Validea's guru fundamental report indicates that ELEVANCE HEALTH INC (ELV) receives a 79% rating based on their Low PE Investor model, which is inspired by the investment strategy of John Neff. The model identifies firms with consistent earnings growth trading at a discount relative to their earnings growth and dividend yield. While ELV passes criteria for P/E ratio, EPS growth, future EPS growth, sales growth, and free cash flow, it fails tests for total return/PE and EPS persistence.
Elevance Health Inc. (ELV), a large-cap value stock in the Insurance (Accident & Health) sector, has been identified by Validea's Low PE Investor model, based on John Neff's strategy, with a rating of 79%. This score, nearing the 80% threshold that typically indicates model interest, suggests a moderately positive outlook. The Neff strategy prioritizes firms demonstrating persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield. ELV meets several key criteria of this model, specifically passing tests for P/E Ratio, EPS Growth, Future EPS Growth, Sales Growth, and Free Cash Flow, indicating strength in its valuation relative to earnings, growth trajectory, and cash generation capabilities. However, the analysis also reveals weaknesses, as ELV fails the criteria for Total Return/PE and EPS Persistence. The failure in 'EPS Persistence' suggests potential inconsistencies in its earnings track record, while a 'FAIL' in 'Total Return/PE' indicates that its total return may not be sufficiently attractive when benchmarked against its price-to-earnings ratio according to this specific model's parameters.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment